throbber
g E
`
`Ch/ca CA 95927
` wwmww P. 0. Box 3505
`
`
`
`10.20.2015 12:27 pm
`
`326491
`
`ASAP Order
`
`Source :journal of the Naticmai Cancer institute. Monographs
`
`Volume :
`
`13
`
`1092
`
`11%: 117-23
`
`Author : Lee M,DraoL:E EvI,.Zia F,GazcEar A,OEe Hfiepler C3,.Beiiot F,Tarr C,i~{ris R,Mo0£iy TW
`
`_"_[i_t__l_g;__: Epidermal growth factor receptor mcmoclonafi antibodies inhibit the growth of Eung cancer cell lines.
`
`‘L...§Titie Page if Avaiiable
`
`Datestamp
`
`English Oniy
`
`§fff_§Ts2fJie of Crmterats if Avaiiable
`
`£3 Color fifth/aiiabie
`
`$.15 Extra C392: :1
`
`[3 C.‘@;:yr‘ighi' Page if Availabfie
`
`?L:§Hardr;opyOr1Ey
`
`{Li incifiude Suppfi. !\«'EaL'eriai if Avaiiable
`
`Digitai Oraiy
`
`HTML,/Text OK
`
`mates
`
` a
`
`£1‘.-o::ur7':+::\.t
`a For m-are .
`
`.
`
`..
`
`5 to cc.=5.3yr:-.;shE iaw.
`
`
`
`
`APOTEX EX. 1020-001
`
`

`
`APOTEX EX. 1020-002
`
`

`
`
`
`15:355‘i3
`'
`Number 33
`
`
`Eizmmei E«rodm°
`
`.33?i3‘6C&§3$f. _;“v"atz':3mz3.' Czm.2:er Ineeiitufe
`
`Susan Mrssiiazzey Hubbard
`Illirezstarj. I;z.£e:‘na.tiarm3 C.-Emczer .§Gz»fl9:~n2.a§ia.n ~('.T'em‘.szr
`
`Julismnsae (fihagpeiii
`Chzief; Scientific Pzab2z".e*m§£an..§.? Brcsxzciz.
`
`
`EDITQRIAL B{}A.RI)
`
`
`
`Baniei C. Ihda
`
`.EEdzCmr~£n—£7fz.ief
`
`Wiiiiam J. Biut.
`
`Blumbszrg
`Pater
`Jean 17}. Boice
`Bruce A. Chabner
`
`Richard. L. Cyfiyk
`Charles H. Evms
`Thcsmazs A Fieisher
`Ebiicihaei. A- §="ri£>a:in:<an
`Bimai
`Ghush
`
`Eli J. Giatezteizi
`Michmai M. Gattefimaxx
`P»<.=.tar €}ra%enwa.Ed
`Rebert N. Hmayvez‘
`fianiel
`I-{Mb
`Susan M. fifxxbbard
`3.a.:°r3~£ett';. S. Kmmm
`Steven. M, Larsmx
`Lamzsé A. Lic:st*§.a
`
`.Dr.>ug3a:§ R. Lawy
`Kmneth {}ld»:~m
`
`Jana: J, Qpganhaim
`Jcshn R. {}rt.aiti<:s
`.E~§m*ve*.y Z. Pam;
`flavid G. Fapmck.
`Alan S. Ramon
`Jeaffrefx? Snz:h.l<:zm
`R3-ckard M. Siman
`
`Sm::.rr'§ S. Thtyrgarssrm
`Eviaxgaret A. Tucker
`3. Faui Van Ne<.~.vei
`
`
`Eric J. Seifier
`Rm}: Iieviezzs Ediiféf
`
`Marc: E. Lippmzm
`Ban L. Imnga
`
`Iél-I}I’I"f3RIA.L ADVISORY R()A;RI)
`
`:.32szm‘-as E3. fiarmitaga
`fitness «C3. fiaguiay
`Jurm L. Biszditar
`{flizarza D. fiiwmfield
`§:'i£az1j.amin B0m2.vi:§2z
`}°3s'w2§s*3. (3. Rczrsien
`{§€2£)t*gx: J. Bus}
`Eciwarzi firesnick
`Barry ilmwn
`T1iz:g~{3h.<2rx (firms;
`Harvzzy J. {khan
`N(3§'m§’n‘.t fiiniemxmrs
`0. Michwai Cmwivin
`’i"hmm3.S H. Cfirbatt
`Rik. Ikerynck.
`Johanna T. Ifiwyar
`Jairm 23. Katie
`.E5{§‘%l!"$’fi§. J. £igo:3ri.n
`Virginia ‘L. Emxter
`:‘«’m§ae>:-:0 Fangs
`Jlsamm
`Feitun
`Isaiah J. 2“iciE:'¢r
`Ilmvid §’it:.t:G=z2‘rs9.1(i
`?}3Ci!I1»“:béi R, Z*‘Rem.£ng
`
`§i!;.rst..~3i;ca i5‘ud:r;ta&
`Emii Fmi Iii
`Richard. I}. Gelbssr
`Bavid W. (laczixie
`Haervey M. iksiunxb
`E1. Eimhwa» Grwzzbsrg
`?"hiii;J I}. {}r‘e‘.eénh4erg
`3-ixesantsth R. Hasrrap
`3.ngs3g9‘tti E~is2i§.;<é:réSm
`Méaureeta
`E<§e.m:iers;zm
`maria 5%}. Eieppner
`E3. {741rmm;k Hoimmlx
`‘Wazzn Ki I-"irmg
`Wiiiiam J. Fiaslizixwa;
`Rehert C3. Jacksmn
`Ra:nr3.~;E1K,. Jefimaxzen
`Wzifiisam W Jchnsmn
`‘Cha.rEz?s M. Kmg
`éitaniey J, Korsmnyar
`Kuhn.
`Kxwach
`M/zargaret 2.. .i?5Zripke
`Slmnaid ‘W, Kufe
`Jabs: S. 1.3%
`firiggiri G, I.ewsnt.§xa.i
`
`Bernemi L2avi.:a
`£’k3‘m)¥wi J. £x.wi.tve
`.8rias.ra R. Lae3*‘i:sr:<r§~€.¥s3In«z.<s
`Mlan ES. Lichmr
`§Jax*id M. Livingamn
`Kfirginiaz A, Li‘§.z‘<.wisE
`J<«:.=m—Pie2r2'<a Mach
`Lmais Psfaispiéis
`{Say Ms::C7iung
`‘ilazmiszi B. Eufiszifermicix
`ffigxhard S, Ivletacgar
`Bwarge K. Mi-zzivzaingxmzixza
`émthany B. Mi.Ei£°r
`Me1Eca}.m S. Eriitckell
`Man 3, Mm'ri.acm
`L88 M, Na-dier
`(3. Kent. Osbcsrm
`Dzwid M. 02;:
`flavifi E’. Fauisms
`Sisi.ne;e' Peseflgza
`Lxzzcter Petans
`Thmdxzrss L. ¥"hi1Ei§:»s
`Hésxry C‘. Pita)’:
`
`Janet S. fiasszky
`'I%2a.ig3}3 .31.. Rtfififéiii
`Igor B. fiominsan
`Rusth Sagas‘
`Shigeaki Siam
`.1}av:Eci. 5‘s¢:?h:>%.§2snf<sk§
`Wiflimn R. Eéhapim
`Ilicy
`Shara».
`Kendail A. Snamts
`Pam-1 M. Sazxéei
`Us-‘sias ‘.5ia1t.n13.t3
`E-‘iarmmz. D. Suit
`Rsa.ym<mri. "i“ae.t.ia
`hm ‘l‘a.:3.m:w:}-1;
`Jae}
`Tappzsr
`{fox T=z2r9m)z§e?:
`J. Tfims Thigpan
`Giargin ’I‘r"i‘:2»:%2i(s‘ri
`Peter R. T‘wesa1§.y:m.&m
`E, Bernard Weinzsizaiax
`Bhamz: W. Weiss
`E-Za3.:mam:i M. Weigh
`iiarald N. Wggan
`
`APOTEX EX
`
`. 1020-003
`
`

`
`EI)IT€)RIAL STAFF
`
`Scientific Elditar: Jaxrmz L. Muizmime, Ml),
`
`Muntmgraph Cianrdinatort Edwin 3%.. Haugh
`
`Manuscript Cmzerdizzawrsx I-ieien B. B§ac};.wcmd., Julia $‘3%i"1¥;€}.I1 Redmmd.
`
`M’axms~;::riy£ Edfitnrsz Meiisga Anarimwsg Bunnie fiavis, M.a3*§.Ey'n K. fNc'.i.3s:)r‘2
`
`Praciucfi-¢:m Staff: Eizzine: Ftica Beck, Wayne: Bixiingér, Camh: J. Radrzr
`
`
`
`VMARKETINQ» ;S'I3%FF
`
`Marketing Ifiirecmrt Vlean C%L:riffiz1 Baum
`
`Promoiinn Serxsicezsz Jarza 3. .I0hn.s.'-wn
`
`EBITORI.A.L P(}1,;ICY: Manuscriprts from ‘Easy (';GIif§3F€tII‘{3-13%; deaiimg wiih €.‘~Ei{)Cf:‘iT and cimczly
`related ressaearazh fiezkia, or a :*eI.a:e:»2§ group of papers cm specific suhjezzts; af imporaanse ta cancer rescarch,
`are mnzaidarsd for ;::1.:i:w§i~::.aEi::-:3, with the mxcisarsmntiing was they have not hem puitxéished Vpmviouflgv and
`are: subinitieé axciusi0139.31}? in fmzmaf .«:>f‘:iv:e Nmficmaf Ca?2<:e.r §n,3‘I£u£fr? ME::snc:g:'a;3}s..s. Ali méateriai ssxisnaimad
`‘far censidxzratiorz W331 be s1s0bj=ac:.::::mv&ew, wlfzen '21§.¥pI‘<:rp'I‘i;3t.¢i‘., by 0:3 Ems: {Wm auisiaie: reviewm; and one:
`membtzr sf aha: Editori3% Board of the .i«;:::rm3.? qfriae Naffomf C‘xs:2s:er Ir2.s:i:xm>. flpéiraions expresma by {he
`auiimrs art‘: I1§)E.I‘ai‘)CB.§S?L?§3}’ {base of aha p1xb.l0ishcr E)!‘ the editors.
`
`Fropcmia fear mazarwgmphs shouké be suhmitmci in Trim E§dét(3r~in»C'h.ie;°.:§} Jwrmzi cf she Na:‘imm.§ Cancer
`Irzxfizuie, R. A B§0:.:¥3Inmrz12:t.i{ma3 Caxaceér 1t:fm'1m1im1 Cranmr, Bmifiing $2, Rmm 32?, Eéatinnal Cancm
`Instiiuzxs, Bammdag MI} 20% M.
`
`Jmxrnal ofthe Natianafl (‘lancer institute Iwianugrapha are: far 24332:. by the Sfiupmmemient of}3‘«z>c::2::m2nts,
`{.13. Govemmmi ‘Printing {f3i§’£"me., Washixigmn, DC ,?.{'}«W2. Fagmxéeni is requirexd in advance rm .33} (mars,
`and chxscks or mrmey wrders stmuki be: m£i{§€ payabkt. in the Sup»mtin.tsndam£ 03’ I3ix:>c12:m.ents.
`
`APOTEX EX. 1020-004
`
`

`
`Bialagjy 0farza' Navei T7'zerape0;ezic Apprmzches far
`Epirizeliai Cancers {If the Aaradigesrive Tract
`
`1992
`Numiver 1.3
`
`(ZaI2tents0
`
`/
`
`
`
`ix
`
`
`Preface
`
`‘
`
`1
`.Inimiimitir3x&
`Jack A. Ruth, Watm Ki Eiong, Iamas L. Muishirze
`Rule ofBiniog and Prevention in Aerodigestijve True: Cancesrs
`3
`Pam: Greenwaid, Haxfiei R. Stem
`
`Freveniiozx and Themgestive T Cancers
`Melaaxzzxiar Apgaraacheg
`
`lfack 15;. R9111, Tapas Mukhmpadhyay, Michaei A. Tainsky, Kang Fang, Man G. Cassnn, Fan} M. Schneider
`
`e {as Gem Famiiy in Human No11--Small~CéIl Lung czanm
`0
`23
`Rabazn 30 C. Siseboss, Sjoerd Rudenhuiés
`
`
`Isiarfiy Even 0 the Nmpiastic magi’VVVVVVVVVVVVVV0tion at Respira EgithefiVVVVM
`Micémwi 31 Eixmr; Rlmda Aiani, Frank Cutting. Lisa
`Fmis, Anita L. Sabich, Ifzmnis A. Eiandem,
`Iili M. Siegfritd. Eva Ezabiz, Paws}
`Brawn
`myvc F5 mus. fixmgz-mi ‘rumors and Tr fie}! L-in
`Patients with Smailwfleil "Lung Cancer
`
`3::
`
`0
`
`_
`
`Bruce 3 iahnmn, Lfohn R‘ Hremxam Daniei (3. 113136, Adi
`G:azdax
`M05213 far Cempmventian of piraztnry Cam:vvvvvvvH
`
`C. Mnszm, Kamiaia V. N. Rm. (fatal 3. Ifmaisac, Gary I. Ktsiioff
`
`Chemnprewxntisre Stufiies in Barr°ett’s Esugahagusz .9. Made! Praxnalimaut
`51
`Lgsmn far Esophageal Aéenncarcinnma
`
`Sampiimr. M. Erian Fennerify
`Eiarindzr S. ifrarewal, Rigzhard
`WWWm
`An Animai Mada! for {lira} Cancer
`55$
`Timmas I. Skxga, Erma B. Kfiimtmewflunti
`
`Expan ad‘SurfacA.a9ocxa0' ted
`A Bbiseriminani fietwem Bieiagir: Subsets
`
`
`in P~E{m~=Sm ‘Lung (Ia:
`61
`
`R‘ Iimiia Limmiia, iames EL. Mulshine, Seth M. Sminberg, Add F. Gazdar
`
`'£‘umm°.1igeu Phermtygra, Bfiulaficé Stagng, and Prnwask in Rem! and Knack fiquammzs Caminnms
`5?
`Grezgnry TX waif, fhamas E, Carey
`
`at‘ Expressian :1 phaspheryza9;a% Iain NormvvvvH
`vs
`3.11% fiigagiastic Keratinacyim
`
`
`
`Tlmmas E. Carey, mam Laurikainen, Tfémnkam S, Nair, ’I‘imo:hy S. Reinke, banaid E. Caazsling,
`Cimgery Wolf, Caster Van Wags, Monica Lisbm, Qganthia Marceie
`
`
`
`APOTEX EX. 1020-005
`
`

`
`Kemtinacyte Bifferentiatim Markers: Involncrin, Transgiufmminase, and Toxicity‘
`Rmbart H. Rice, Qin Qin. Arm-:2 P§_§at0,.,e4.mc1mw L Fiiwita
`
`Csnntral nfSquamvzmsnifiemnfi;fi ai Ceiisz
`Rule nf Retintzifis
`
`087
`
`93
`
`Arman M. Jamn, Cliara N¢rv§., Thmnias M. Voliberg
`
`Suppmssitm by Retixmic Acixi ofEpidermal VGmw'tt’: Facwrwfieceptor Aumphasphoryfiatian “
`and fiilyeosytafinn in Caiturezi Human Heat?! anti Ntsck Squamnus Carcinoma {lens
`Inn 8. Kim, Peter A. Eiteck, Gary E. Gallick, Iain S. ma, Mari»: Biicik, Wmm K‘ Hang. Rm:i:«zm {man
`
`
`101
`
`13»cis~Reiinoic Aerie! arsfi Cancer {Zhemapmventiem
`Scott M. L§.ppmai3. Wmm. Ki Hang
`
`
`
`
`113
`
`Epidermal {§‘»mwi1z Factor Receptur Mnnacianal Antibodies Inhibit the Growth of hung
`Cancer Cell! Lines
`
`111'}
`
`M. LEE1, M. Dragui, F. Zia, A0. Gazdar, ii. 036, G. Bepler, F. B61101, C. Tm‘, R. Kris, T. W. Mtxaiy ‘
`
`Egnidermal Grswtfih Factnr Reaeptszxr as a Target for Thvemgry with
`afintireaeptnr Manmsimlafi Aniihodiw
`..'f:)}m Mmdgiscahn
`
`125
`
`
`
`
`
`0
`Systatic Bewiem BomGastrin~a3£asing €12 Ants
`David H, C33’, Rabat! T. Jensen, N§.ng«Yi Jiang, 3awmTr.:«wn0 Lin, Anthur E. Bogden, Jacques»Pim’e Mcreau
`
`Mala: Genetienai atTlliistimitaceprieé Mammaan Bo.in~¥;ike zptiii
`James Barbs:-y. Etsukn ‘Nada, Martha Curjay, Jamas Way, Zalzra Fathi. Hagit Shapira, Richard Barkins,
`iames Wu, Timothy Siaitazy, Eiaina Mann, Richard Fclclman
`
`
`iiflrects atfiemwpepfi onn g mama-.9: am‘0
`P311! A. Bum}, J12? Bavié G. Bienharz, mxziefi Chan, Manrean Tagawa, Wxiilip Jewetft
`
`0
`
`3
`
`141‘
`
`1;;
`
`153
`
`
`
`163
`
`Differential fitimtllation at‘ the Grawth air‘ Lungemetasmaizing Tumor Cells by Lang (Faméfina)
`Gmwth Factors: Idaniificatiun of Traxxsfert'in~iike Mitogens in Lung Tissueaflanditimaed Medium.
`Garth L. Nicoiwng Philip (3, ~Cav.anaug}n,. 'l”a.katoshi Emu:
`Expert: 92‘Puma Efimwssinnzymin Mfimzéine and fiearaendoce Cells
`Eamjy A. Elippcr, Ciziazina 'B«R, Green, Rizzhard E. Mains
` “
`{3m2!m§ ofTamar Ceii Biology Thmugh Reguiation at Peptide Hnrrnane Processing
`116?
`Anthony
`Tresmn, hangs L. Mulshing, Frank Cuttizta
`WM
`Biemarieter Intemmiiate Emzipaims ami Saucer firavenfimz
`1?“?
`Frank: L, Meys.iv:.ens., Jr.
`
` <<< < « ‘wm
`.Rmi«ma£ Targets for the Early Betacfinn of Lung Canoe:
`383
`Jmneas L1 1‘:/Iu.¥.shine., R. Hana Limwila, Sandra
`Jensen, fishy: L, Magnani, Melviti S.
`Gupta. Frank 5. Scott, Ingaiiii Avis, Kathryn Quiml, Michzwi J. Bimitn Aniémny M. Trcstmz,
`
`
`
`
`Prahofih K,
`Cuzszitm
`
`
`
`vi
`
`APOTEX EX. 1020-006
`
`

`
`axssmiaticm Retwesan .Hisml::agjcai Type am Neumendnerine Bifferzniiatiun am Iirug Sensitivfity :11’
`Lung €3a:ncer Cell L-ir;a3
`
`Adi F, Ciazdax, C. éiadoyaméa, Dzzvs.-‘id ‘e’e:1z0:1, ,§;=::e~Gzzh§3 Fark, Chun—Ming Tvsai, R, Rama Linmziia,
`James L. Maishirne. Bazaiei Ci. Ewe, Céiustzppe €3iacx:.gmc
`
`fiamfiinatian Inznnunmhemgzy for A.£i1?a.z§ced ¥.samg {ifzmtm
`S‘te:phe;n
`‘femg, Eiimbctah A. Cérizrun, Jack A. R0211
`
`Aimmuxmlagic E§f§’s:ctu~r Cells in Head and Neck Cancer
`¥3r:§m£:nim~ Vim.§o, am: Mdivatassieré. Xmas T. Ioimaorx, "1?22eres.a L. W.§“1ii£3i::§:=:
`
`‘List 9%‘Speakem
`
`P*ar£icipant'i}irac£s;wy
`
`
`
`E91
`
`E97
`
`383
`
`309
`
`311
`
`Acknawlewrlgement :9 Manuscript Reviewers;
`
`0£~‘zma.n 3ar:§cs«3£?h£i€ge!. Pix.£}._ iflaaienai Heart, Lung, and Bicmd Instituzs, Bathesafia, '£s«"1a.ry§ami
`James F. Barzeay, MEI). , Qzberatory4:3f'8i01ogi2a.1 Chasxmistry, Nzazietmai Cancer Inszi£1132, Bethes»
`iia, Maryianci
`
`fi»1iam‘;.aeI Eirrgr, M.3.'I1., BiV0m0a:‘i<e2s and Prsvesnaisan Ressearczh Bramsh, Naticanai Cancer I£1.5{§i£li€‘.‘-,
`Eaihesda, Mazjylaxxazl
`
`{'33:}: Erzzwley. M’.D., 0?%Ia%.is;m.aI Caracas: institute, Bt:‘th\£sda, ?*/‘{é1:aE'}"I,2£§}d
`Pz:n»;-«>3! Iimwrz, M1), Pix. I1, '8iumm‘i.»:m and Frmexzniaza Reaearch Branch, Natianal {fzmcer
`Institute, Bet%1as;iz:,.Marykand
`
`Pcmi Baum, Mfl, Uaxiveprsity {sf Csaioratjo Health S~::iencc,: Cimtetr, Denver, Ceiorado
`Yhamaus
`ffarey, }’§z...€.3., Uniwmrxity of Mi«:::higare., Ann Arlzm”, "Michigan
`Fmmfi: Casrirza, }’*iz.£3. , Biumarkers and Prevéentism Resaarch B‘:‘21nc.§;, Nazimiai C.ésn:;:§:r '§'n.stimtr:,
`Batizesda‘ Mmryiand
`
`R’<2§m"z B, £)‘ic‘.§ms"()fl, Fi2.£)._. Lambardi Cancer Rasazmzh Cgnmr, W'a5hingmn, DC‘.
`Au,m':2 Davie, M.iL2., University 0f fviazyiand Céamter {Z‘.’enz.e:r,
`'8a1ti;m::2r::, Pviaryimid
`Wiifixzm 1'3. ffammamfi M £30., Ejzmiversity sf Caiifumia « Davis, .i3m'i;~2, Caiifmmm
`Wamr
`Hitaiemrmx, 832.13,, University mf ’i"e.ms
`1). Andersen Ci-ltitfifli." ET::nter, H'r;z:.1:;:;::m,
`Taxes
`
`W&~2z;n Ki Hang, M.,2"}., Un:ivarsii‘y zrf ’I‘t::c.;1s M. 1).. fixndmrson Czmcer {'3_e.r:0:.e:r, E-Im:st{):1, Texax
`1Z)ar:ier.Z’ C. Ihde, M, £1, .{}e:pmy Birecmr, 'Na:i.m1ai Camzer Enmtmta, Baahesxia‘ tsiargeiand
`Bmms
`Jnfzrzsorz, M.£)., 5N{Z'I~1“$av'y E‘v’Imiica§ {)0z1a::e:3in«gy Eranch, Nr.»1§:ior.::s3 .Nav:-ii "mkadicai
`Csmtezr, .Bezhesda, Maryiand
`
`faizn £9’. J'm.s:s, M3,, Biujmarkszrs and Fmwmicm Research Branch. .Naiim1a§ Cza:m:s:r itsstimte,
`Eeflmsda., Ma2*y1aud
`
`Phiiiip £3. Kezxgrzyk, P:‘:,1}.0, Maiecuiar {)r2.m§w:%g}/. 11142.. (}aiE§1::r3burg, Maryianci
`.B:2rr:3z"z 3. Ifrarrzer, ,-Mil)‘ . .D:§‘vis2.io,r.§ (sfCancer §‘r¢‘£»'°€ti£i(?I’.t
`;m—s;i Cmxtroh Nagietmal Cam:er '§'nssaim:e,
`Béihfifidék Maryiaxad
`
`£3. And=::rsa}n (‘fan-szm‘ Center, Hm1sI:;>n, Texas
`Km 5. L88, M. 13., University of Tr:-xzss
`Mcz.r.¥c zezeizr. M.éf3._. 952.233., Pittsbu.rgh Czznmr Emszizute, fitwisburgh, Pzmnsyh:ar;.ia
`
`‘vii
`
`APOTEX EX. 1020-007
`
`

`
`Epidermal Grmvtlz Factcar Receptnr M0noeh3na.l A0nt:i‘£mdi&s inhibit
`the Gmwth af Lung Cancer Cell Lines‘
`
`M. Lee,’ M. maauif 32. 253;‘ A. t:;m1ar,3 H. t’.‘Ziive,7“ <3. nepsmfi F, Bezzmf C. Tarrf R. i_~:.;~is,*‘ TIXW. n.iaad;*W
`
`.A.1iSTRA(.Z".{"-~The ability of nmmtacfionzsi antibody (MA!)
`238}, an i1¥lmIifl£)git}hifl§fl {S2 {Ig¥I}}2a ag.:3in.s! the vapidermal
`gmwéh facimr receptor {EGER},
`ta interam with tang
`mzracer ceii
`firm:-rs was éxiveémigaieri. mimfiitéiii‘ haunt} with
`high affinity in E‘£‘1’lK1~SB§‘l§§s§§*€E.H hang cancer £3”-¥S{1.I;C} mils,
`and MA}; ‘£93 inhihiteti s;wx::i¥‘i¢: tfixtaiing air‘ aims NSCLC
`wilt iimzesz in £2 :i«0se~d<mendm:£ mamter (E15,, == 00.36 gxg per
`ml). ‘”I«‘MAb 1:293 bmmd with high atrium G26 m 2 am}
`:9 a single class of sites {Bmam
`‘I6 {W} per 4:911} using
`NSCLC uenzraendmrrine celi line E‘*éCi~’H468. Speeifix: ml»
`MA}: 2188 finding was izmihited with high affiniiy by MM}
`‘:33 km rm: by R mnirsnfi antibody Igti} casing ¥arge~ee£!
`carcinamg 2:213 fine 3‘a‘-Ci-H3299. “"53?-.MAb 1203 hinxiirig was
`amt.
`iniernaliré<:¢:i 31 37 “C using NSCLC neura:vencl¢:r~rcrine:
`can firm NCLH460 and adenmrarcismma cell
`fine MCI-0
`E-123. Also, 1 fig per m! M‘ MM) 103 but am :33’ 2: wntmi
`Ig{3
`inhibited the: china! gmwih mi‘
`.?"€CI~i*i33
`anti
`zaqmmmus set! carcinoma cell
`line f'*¢Wf;?I~H1§§?
`in vim).
`Aim), MA!) 3.03 iuixiizi-mi ‘xenargraft fztrmation at‘ caaif tings
`f*~f{§.I~Iis¢6f¥, E"4(3i«-Ivi15‘?,, and MCI?!»-.H‘?2«7 in nude mice in
`viva. After 2 gmiipahke tumar ham} §‘e:r:mz:§ using N=CI~i-iévfisfl
`calla,
`injfifltiofi of mi} ;;g :3? MAB» E93 {intraperifitmeaiiy
`three times w0ee£.«;.iy} inhibited xeawgrafi. miume in mnie
`mice by approxim0ate§}~' §{3*5~"::» . Theme. data suggest that MAI;
`ma rxzay interact war: EGF revcepiors on hing can-tar ateii
`fines and ini.zihi§ NSC”-LC prsziiferafima. [3 Nat} (Janet: Inst
`Mung: §3:}1"3'm§.’Z.3, 199%
`
`Thu: szgjiécicrmzzl g.r<:<wih fE£C!.£Jf recepéor {‘E.i1‘rF~iI?i} is .21 I236
`a.mim;s acid protein cmnpriaed of 3 621
`axnirm acid
`miraceiluiar daznain that <:0nta.ir:.s £31»: epiderzzml gmwih
`factor (HG?) bimiimg site,
`fc:i§{2wc=d by 3 23 axnimr; acid
`t:s‘ans;':1mni:m21na domain and 31 54?. aznimz: a::.i:;§ c);tcss0§i.a:
`
`‘
`
`1‘ Suppimevd in part by Public Htzaith Ser'vi0c.~e g;:-araéi ‘CAwé$£%”.?i
`from the Natirzsnéal Carzcer
`Imsm‘tuie:, N.2m79na.i
`izastitamss of
`Eisaiifix,
`€2ep0art.me:m s:>f Eieafith and Human Serw‘r.:e.s.
`‘Bwarrmm:
`:3? Bia>ch::m.ism;* ami
`e‘«v€§c;§c::'uiar Biaiagy, “ffze
`Gexrwge Wash.i:1gm::
`f..Em’vs:,r;\:ity s‘v§miis:aIi Cazzmer. W.a:s§1.iz1gt~cm,
`D12.
`3 NC.ImN:>wy‘ Me€!0icaI§ Qnmmgy Bmmzh, himiaanafi
`siiiaatzz anti
`E-£»Jsp§ta.3, 8r;th»*::=,tia, Mei.
`4’ §}ap§mme:1t of Medicim, D113-zit ifiraiwrmiiy Meciical Cemcr,
`‘£)urhz1m, INC.
`"_ Kara: 3it3£&€h1‘1£3§0gi£$ Elm, }-img M‘ Prussia,
`“’ We: Emmi»: Dr, 5. 8:31:33‘ and Dr.
`03‘, E$a:h§es:;img»;:0r far ?1£3.§;'3f‘£1l
`d.iscussi:3m;.
`’§’.W, Pvimmy, .D,, G‘Wi.§ Bi0:;:hc3n':.,is«
`? €;i‘arre:;pande:zc"¢>. m:
`try {)epartn1:mi.
`Eggs 3:. N,W,, Washingmxr, BC 2{)€}3‘.K
`
`tZZ2m:.:er in»
`
`dxiémain that £251.50 tyrm.'ine kinaae activity {I}. "Wham "RC3?
`bimis to the E{;‘:F—R_. ¢:3;:*0osir1:: msicmes am phasphoryiaaeé
`on substmms such as; the C?~terznina£ of the .E';CiF~R and
`p§1c3s;1ha£idy3 i:1osits:s£ is mrrxed saver, cyaosméic Cfa“ is
`sisvaieé, the c;m:=opIasm.ic pH is im:rea.s::zi*, the i~EiG'F~.R is
`internaiized, Vand target ceiis Vizmxcama cmnmémzd ta S3-*I}f§1t‘:m
`size {LENA and éivide {2~5‘}.
`'I.”h.s;: ECERR has strucmmi
`simiiarities ts} the v~c':rb;B cnmgene (:5).
`The E€.’3F»R has been de:.e:cu:d. in mamy na;1«sm.aii«ceEI
`lung cancer {Z‘~3SC.LC) but rm: in srnalkceit ‘mag cancer
`{SCLC} cefis (?T,S3‘ N$f3£.,C CEHS stwnthesize mmsforming
`growth facim ex {'¥‘{}F:.y}, wh.§»;:h binds U3 the Ef.%.:F’«R {fl}.
`Be::m130e m€}'i1{}{3l0ii€i}
`amibazdiea {MAbs} agairsst TGFCX in~~
`hibit time gruwth of 50838 NSCLC 2:513:-3;.
`’§‘{}Fo.= snag? hr: an
`autmzrinée grawtb facutszr fear game 'NSCL§;‘: ceiis (103.0
`it may aisxzs be ;303si.hle m imhifiit the growth inf EGF-R0
`p+:_::ai£.im :;:e§1s using MA%3 against
`the EC3<F«R, Préeviazxsiy,
`.i*«/:£Abe; such as 51138 and 225 inhibited ihe gmwth of A43}
`vuisra.r
`srigammous-: carcimma {A433 am} mics‘: azfienacar»
`cinorna {SW943} xemgrafis fin axhyrnic mice (1'.{,I3}.
`In
`partisrular, MAR:
`.7125
`inhibited EGRR bimjiing and was
`im<:r'na£ized,
`.r«::suiz.i:1.g
`in mine and t.h:'c:(mine, but not
`tyrusina p§1{:s_;1h:f1r3;'Eaii(3n,
`at’
`the ECEER {‘:*3,!4). A.l$m
`M‘A'i:s $08 inhihitsd me grcwath mi‘ ma! epiiiermaisfi {KB}
`Mcarcingméa mnagrafts in 1:u0<£a rnicraa (J!-53v 'M.=‘&.i3 £08 inhiho
`.ited high~afi‘in.éi.y‘ EGFJE iainding,
`.¥:1GF»R tyrsysirle grams»
`p§wry'£a£&ox1,keievaslion 0? cytaépmsmic pH, and cievatimz 0%‘
`cyz:r:sso§i:: Cfa“ {I5}, Here (he abiiiiy cf Mab 308 m inhibit
`E{3F0~R binding am} NSCIJ13 gmwth was .§Iwest:igaic{i.
`
`MA'i‘ERl'ALS AND ME’? H6138
`
`Ceii ifiuiture
`
`Humara ‘iung cancer eel} iim:-rs were e:,:ult1ur:::i in sersum~
`sazppiavmensed medium {RPM1~364€3'} comaining i€§"J*‘a h:2ai«
`im<:t.iv:»m:d fetal ¥::s::n.:im: serum: as; 37 “C as d<:s«(:m'§::r“:(i pfiiv
`visously (II 7). "me NSCI_,C £231.? iines wmr a»:§.heerr:n: and wen:
`51:21:’: wevekiy in 61
`.§:2{1 ratiia using 1:},-*psin.fE;I§:)’I‘.»& {IF}.
`R.:3u:.im:ly,
`the a:s:%Is hm} greater than 90% viabiiiay and
`were m1»’C0p.¥asn1a frag. The cells were. zlsed when they wmrszr
`in am e.=<p~(me:1:ia.¥ gmwih phase. "fen hing cancer ceii iimssa
`mat bmami ‘E€Z}-F with high affinity W€:}“Ef euimred.
`
`R.2mpi<:r Binding
`
`"file z1b§2it3.>' 0f MAE70 108 to §.flhib5’E .E’.-GER iiziziding was
`investigated as describezi
`prsv‘§u‘us1y
`{IS}.
`fvmb £08
`
`£17
`
`APOTEX EX. 1020-008
`
`

`
`3 is
`
`LEE 8’? AL
`
`tigfiaa) was jproatiuced after ingestion atf rnice with {;‘_i~eI.{3
`melts transft:<;te=:f: with a piastrlitfi hearing :3. :.:};)NA construct
`at’ the. mxmtan E.CiF~R (MW recaptort that 681%}. Spitmn ceils
`t:xfimn1:_mi:«~:ed mice were fugeti with I*£St{3~i zttyafionta €e§£S‘I
`‘Tm: hybritiomas secmtiztg Mains against the BCERR were
`saiecttati, cianeé, and injected imt: mitlft {I6}. Ascites fluid
`was ammenium ‘S1£1§7Ei.t€ 3prt::t;ipit.atea:§ anfi I*»*§.A'h 188 gxurifietzi
`on a pmtezizt £%.—St:pi1:3:<t;~s:: aoiumn {tSi.gma Chemicai (Zen;
`St. "Louis, M0,}. The NSCLC a:::l.§,s were }1am:st.t:z:E aftar
`treatment with tryjp:3in,»’IiiD’I"A anti 5
`130* salts were
`added to Efiyweli piatm, which Wm: j§T)I‘»f¢tf{’~9Itk'S.tvt?»§§ ve:ith 20 tag
`of human fibrotteciin {Sigma Cite-.tz1i.c3E 130;). After 21
`nmmsiaym’ sf’ czeiis had ftxrrriaad {3 t‘i:,>tys»)t, the Ce}! nuxxxbtsr
`was dté:ti.t:rm.§.ned anti reuepmr binding smciitrs ware con»
`tiucted. This salts, were washed zfcmr itiméa with $017!‘ media
`{RMfPI»164{} zttmtajning 3 x 1t'锑* M Nagsetg, :2
`tag per
`mh itntamiin. 38 mg get mi. i.mnsferr'§:n, Sigtna Cihemicai
`£2.53.) antti
`incubtated with ‘25;i—¥i={‘i-F in mcaptar h§.m:,ii1tg
`buffer {SIT containing 9.13.70 bovitm gertxm atibttmin; C3a.§%:Ji0~
`charm }_,a}t:vIia., Ca§:'.£‘.}t. EQBF ffazsjycba, téexv York,
`jN.Y,}
`and 3‘w’MtI:3 108 wt:rt.+ itivdiiiiiiiiil aging the chtoratttitw T
`prone-zzittra and ”5t~'tzt;t«“- (30 poC§ my pig} and ;:'3i~}v’§Ab ms
`(28 #6:? par pg} };’m3fifi%‘fi£i using get? t”ii1:.r:2tt.i0n techniques.
`After 30 nzinums at 3"? “C, frzze ra.dit3§abvaIcd 'pmtt°.in was
`rtzmovcd and tha cciés that ctxniraimzszi bound growth facmr
`dissoiwzd in 6.2
`Na.Qi~i and counttzd in a gtunma
`saunter. Ciotttroi MAE: Igfi} (igtfiiza) was purchaseti fmtti
`Sigma Cimrnistai C0.
`
`fllanageuic Assay
`
`flcli lineg E“~«’CI~H23, 2°~l¥CZ~H.1S?, N(Zi1—H?2’?, NCKHSE8,
`and Ni?!-I0-¥I3.9§ wesrs ttarwsted anti testsad in the agarwsc
`chming fiystem dascrihed garevimssly (393. The base layer
`consisteni 0f 3 mi, of {¥,5% agarose in Si"? meciium cont
`taining 59%: feta} bovéne serttm in si>t»we1l mates {Fai<:on,
`{)3tna.rd, (3aEif.), TM {.033 Bayer sttmsisitzti sf 3 ml. of S31“
`mzrdium in (3.3% ttgawscx, the §ae;:rtide{s} doubly‘ cr3m:<en~
`treated and 3
`‘:<
`ill?‘ sirlgie viabie 2:2:-zlisa. Far each ceii tine
`33:3 p€p$i~t§t3
`C£)I3C€3Fk£r£1fi{)‘§‘§,
`tripiicatt: watts were §3ia£.es:£.
`Aifmr 2 waeks. 3 mi, of (3. W1: P-ie:2ti::>nit1“o:.eimzaiium via»
`iet was atidted, and tzfmr it? lwurs
`3’? “C the pEa2'.t:s wars
`screened far cofiomy farmation; the rmmber bf {:0}(m_§.~;33
`target’ than 206 mm.
`in diamt°.te.r was cotttated using an
`Om.r;i.::so2t image anaiysis system {Bat1:«:ch and Lamb, 'R.t3t;h~
`eater, .N.‘r‘,§.
`
`{?»mwm Sstufiits in ‘iivzx
`
`‘Ylxe abiiity 0:!" 2‘=«:‘i.Ab 108 to inétilait zttxnografé forz11atit3n
`‘
`In nntir: mice was ittvtasrtigated using the tecfzzniqtzes d¢:~
`s;ribet.*:’previ§m2s'£y (20). Femait: ath;:rnw:§c Bath/‘r: nmie mice,
`4 to 3
`».>ve~.e1>:.s 016:, were haustnti
`tn,
`ta
`;:}athr::g:m»fret:,
`1€m§*€l°a£‘tlf€~CQ1}€I‘0§3ifid
`isaizttitm wont, and the diet cm»
`sisttati of auiofiawad z*0-dmxt chow and 8u{.O-Ciavfifi water
`givtzn mi
`iibfiium. NCi~H}5?, NC£~H~=‘ttEIO, or tNx22§—E~§727
`cans {E
`35%‘; was injected mm the right {tank of each
`mot:sa=:_ by sub<:t::tarmtms injection {2}}. Palpatfltz tumors
`were obsarwszd in approxim.3.te1y 9{}% af the mim after 24%
`to 28 zziays. Phospttam buffered saitine {PBS} (2630 ;£L},
`
`IvI.A'b 01.0% in PBS, :30: the igi} mntrol in F138 was itnjecéad
`émraperimn-::.aiiy, The tumor ‘vchzme {height
`Width X
`éezpth} wax; deterxnitted W'<3<.“5§t§y by caiipers and rrxzmrdteti.
`‘~.«§~"he:} {Em ttntmr Emcattaza nezsmtict the grt:3W{§'i stiutciitzx were
`'i.é31"I!‘iiflI:’£{{3£‘1.
`
`Wht<:n that growth S¥.t£di§S wen: term.inatz<:ci, game mics:
`were injzacitzd with ‘wwviab ms or £25.}-».ig{3 {'it’3" am).
`.After it W?.‘,‘»i’:3s1, the tumor and sevemi orgtms were dis:sem2c§,
`‘weighed, and ctmnteci. ‘Rte counts per minutt=. csf ’25§—?~.»‘;{Ab
`108 at ’25i~.£g{f’: bauttti pm mg ‘wt tisaue xveight was s;3a§C2’it«
`iateci.
`
`‘REESMULTS
`
`Wffkh 103 Bimiijng Studies
`
`Previrzsttslsg, we fauna that m'i'~EiZ"i¥r7 btstanti with high
`affinity its six NSCLCI 2233.3 lines and tr) a mug camgtintztid
`{IS}. Hare specific: mi—§3(l‘t¥ bindiztg was tinhihiied in at
`d0St3»I3£&f[3&§1(i£’I3{ mariner by EGF amsi MAE: N138 taut. not by
`a ~t':0mlml a.nti0b0«ti:e igfi lifiiflg Iung.
`tcarcimzavid NCZ§~H?27.
`Fig.
`1 ShQWS that spztcific ””5I»{i{§§*‘ bintiing was n:im.i.:na.1iy
`inhibited by E 113 "per ml.
`but was ma,Ki£'F¥,2111}? inhib-»
`ited by 3 tag per m1, EGF. The itfjm for BC}? was 38 mg per
`mm. Aism MA}: 168, mi not tzommi 3I}€i‘§)(){§}’
`3.g{3-, inhib-
`ited Sgpecifit: m§~EGF bizidirtg in a dcs3e~d4ep::n.deni mam
`net. The 11135;} fax‘ MA%*::: N38 to inhibit téprscific mi»;EEiF
`
`‘I003
`
`0‘: C3
`
`
`
`
`
`%specific"25:~»Et3FImumzi
`
`(9Fac:tt;>sr)
`
`, Log gimt
`
`Fig. ‘i. lmsihitietm csf ‘2‘.ivf;£3F Evirtdmg. Ttze ahiiity of i-":32-‘ {U}, Evmb 188
`{ and am: Igfjz tctmzrni (A3 to int’-.fi=bit smscifis: ‘*25iwI."Z{3F bimtiing, m mag
`caraézmid cell Eim: NCI«»H‘:!2? was ig’{€£‘5n$fi€dl
`‘Hue ztaean vattmv.
`:1: star»
`tiara arm: of am. mam: {SE} of mm cieiermimttitms is tirmiicaaeci,
`
`§{)L?§?ti“%'A.i.,
`
`NA“TI£f}NAL CANKTER i!‘€f:§"i‘iT’U"i"E M()%\3£¥GRAPH.‘5 NO. 13, 3993
`
`APOTEX EX. 1020-009
`
`

`
`1201* s‘<:3.e;'.éz;m*cm .:m':‘1‘Bc;ntt:ia mu N5.iC¥_.C
`
`139
`
`:0
`bi£}di!1g was 0.5 Mug pm‘ mL, mt even high duses sutztt
`tag per ml, did not K(3§'.E‘§‘§§j'je' intzitrit :‘ztdic;labe}t:z;i EC}-F bind»
`ingt ’I‘h<~;*s::~. «data indicate that “5i~E€3'F ‘minctittg is inhibimti
`with high tam} madssrrtte affitaity, ‘£‘t‘.'$p€3Ci§V£tt}*‘, by EEG? amt
`MAE: £08.
`Wtuzwtfxb £03 bound with high af§’init.y_ ta lung carcintaéd
`um um NC!-1-{"521 Figv 2. mwg that ”'*’Z«b.*t.Ab ms b§.ru;i~
`mg was inhitzsitezci in a d.z::te~de;)entttm manner by MAt:s 308
`and E{‘x'§."~‘. Litatie sgtecifitc bimiing was inhibitrrd 233* 1 mg par’
`mt, MAt:s ms or EC}? wtmrea.s Sp&<'.'-ifit.‘ "25i~§«iAb ‘aintting
`wtzs :.otafly inftibitttt by 3 pg per mi. MA}; 303;
`1
`tag pm“
`ml. 556? §t“£f':ibitI~I5.‘(i must of ttttt ”'5E»?s/ifitb I03 biztdittg. ‘Etta
`Zfim wtiuea far MA}; 1080 tam} RG1? Wtifti 30 and «#00 tag gm:
`mL, f¢3S{38€tiVfi§'y.
`”‘5.§—;V.§.Ab £03 binctimg was rm: inhibited
`by cozttmt Ett1t.i¥30(i§f {gift-t ’I‘t:er»::t'0r»:: ”5't.«fv.tAh 102% ttsimiing
`is inhibittd with high and .m()di3r€t.€.s‘it
`at‘i‘inity by MAb £08
`and EGF, rttspttcziwsty.
`at-':i§ lfinas {’¥‘:tbi:::
`Simiias‘ dam were mbtairmd far NE§_€ZTL£'J
`2;».
`3»»1’.A;.ta ms ix1hi§:s.it..ez;'§
`fipgttific
`‘23.IwEGF binding 10
`a.den0«c.ar=cim):na {:‘3tflL{:7~5‘§W3., N{Z.‘i%t~tS3€§, E\ECI»H.23, and
`Nflhflizépt},
`iarge wit carcinmna {‘¥7~i‘iZTi~Ti-'«f1?;‘99f}, amt
`squamtms Ce?! ararcirmma {Nf;?E'—'Ir'£'§5?, E‘P.L.{.",f«32M 1, anrit
`E§Pf..C»6$}{} with .tC§(, vaiues rtmgittg frrzxm 300 to 300i} mg
`glflt“ mL. in cantrast, Mfxtm E08 wa:~; mam pmtzm at i11}1it3—
`fitting specijfisz m-A5f«i‘s*E.!?U:> 3208 bisiciing wit}; {Cw vaitaefs rang»
`ing from at) it} 400 ng par mt“ These data intiittate that far
`213% Celt Zirm; »:::<ttmin—e:t, E‘viAt> 308 was nmres:
`§3i3£€‘£'1{
`at
`inhibiting ”5§«§viA.b 1.03 than ""‘§*Et3F ttimiiztg.
`
`‘I00
`
`
`
`
`
`atSpecific?25:~«-mabmsbcumd
`
`{.72Q
`
`
`
`“Q . W“?
`
`ma
`
`{Factor}, L09 gfmt
`
`
`M5
`
`163$: ‘binding. The attiiity «:3? EC}? {£3},
`{131’3.i§:3i?ii:i§ at ’3'"‘.i'vZt+t.Atv
`l»"§.g. 3.
`zvmh me my}, am we Igeft mm:-cs: (A-.f) t(3!in3’1.‘i?,'1i‘i tpcc-'.:it‘it:
`i2r‘I"§*>'i$"§.b was
`fzsindixtg to ’NCM»i‘_?::3’ was :E»awrmi.nesi. The mean vzatuzz it
`:3? four
`tkterminatisms. is ‘5i’}ifi%'.fK§%.‘.~Ei.
`
`P3.1i"'§THI€£};lAZ., C.-*.N{'_T‘ERS (W THE A.ER€3IDi{}7t'i3WVE "{‘.§'tA%i'3‘E”
`
`Tame: 2.. Bimiing its N$:;'Ii..€f
`
`tails‘
`
`cat: Him:
`amierzcscarcinctmta
`N{?i~H23
`§‘»I.Ci«1~{€£3t8
`=‘3~ICi~§c~Ii264
`.x‘tDLC—SM2
`Large: tteil »;:a.rc‘ir2-mna
`f~«‘£2E.«§={ 2299
`Squamous ccit carttimma
`E.§’*LC~32M2
`Ej?t;C.~i:}§H
`E\‘57CI-=I~II5”:'
`?~ESC‘L£3 neumendtsgrine
`N‘CI—Ir*I4{$»£}
`Ltvrtg ttarstinoici
`NCi~I~i'??;?
`
`‘3§t~'t3(}i'+‘t{iCm} m'§w?viAb i{}€{{-‘i(:S0-3‘
`
`tut.‘
`1001}
`2{)£}£)
`13%
`
`350
`
`£060
`amt:
`30%
`
`300
`
`.i{}0{}
`
`90
`mi}
`n.d.
`md.
`
`‘*0
`
`:3 ti
`3{3{}
`6%’)
`
`200
`
`‘EU
`
`‘Cans were piatebni in 2s$~we§t gzsiattes and the ainiiity Bf MM? E03
`1:‘; irmihit stssewazifétt
`”5t~ii’-{E-3?-‘ and ”’5i»MAb MS ttittcting detttrn
`mineti. T116 rzxettnt vatma EC“, ingfimh} of three ttetm‘:'nintat'§:3«r§s is
`imitated.
`"n.:;i. m mt" at:-:.t¢r';n‘met1,
`
`'I‘t2.e bimziing Qt‘ ‘33‘t~z‘v‘i/kt: £03 ai)p1”.‘-.i;ii‘é3(§ sttturalbit (Fig.
`3, teft}. A Scatcharci pizza! mi‘ ttte specific binding (3a.t.%1 (Fig.
`3, right.} was §§:'1t:a.r and §I1.£Z§C£ti.€3d. that mi»?\&.Ab £08 bxrsmtd
`with high aft'in.i:y {tad xx 1.2 mm) in it singie ciass of sites;
`(ttrnax rs
`'}"{'§ {ma par Cffili} aging C11‘-H line NSCLCZ neutcw
`{b.3160-(t'3’i.Im Catt line Ntitofiéfifi. Previatststy, wt: fomtct that
`mi-EC}? iaoursé with high affinttj; to £10 000 sites per ctsii
`Lisiszgt wait time N(?t~}§?37 {£8}.
`“’*5Z—.t££}.F’ W35 zrapittiy intematizeeit at 37 “C at’t<-:2" binding
`211:: cat} iitw NC§«H?2? (28). Fig. 4 siwws that ”‘§Z»§\’tAh 103
`sinwty tmuntzi to wait
`limas NCLH23 and N(‘.‘:I.»<Ir*iA't«£§{} at
`at
`‘*"{Z?. After 2 §‘3.€I}£}}'$, atppzroxiztiatzfiy 36% arid 90% at‘ {hit
`rattiotatzeied ;’vtAb 108 cauitt be t‘§§S$0it'§3.i€d
`from the M31»
`anti NCtI.wH<%6t‘a3 tf€Spz*.<:£iveI)‘, by tiihm: taa:ittfsr3diu.m
`athloricia and was memtxtanrz hmtnd. in wntrast, M“_k’o and
`i£i'2% at‘ the ”-‘t“—:t;t»th was mm: snrfid dissaciatzte using t~J{fiI«
`H23 and NC)i»}:I.zit3{},
`res;;.te:ctiw:I:;',
`and was Evtkkthitiziéd
`whm time Catt W213 diswived in ditum base,
`’t‘?2err:f0re at
`4 “C I¥‘}£3Si,' of the bound m¥.«?v?A¥3 was not inttzrnalizazd and
`bsund to the gait stztfavzs. Smtilariy,
`if NC§~H'23 and NC!»
`H436 were first inmbatett with ml—MA.b 1:33 at «t “C: far 2
`hmtrs,
`ttwzz ineubauzti at 3? “if:
`€331‘ S inmates. oniy M’-'€»’u3
`and 15% estf’ the ‘353[»{\»f§.a"&b H38 was iattamaitzett using NEI-
`H23 amt .N‘Ct«£~t»t£§{},
`resps:t:t.ive1;.e, T‘.?t‘f:.5€ dam i.mii:;atc that
`at either 4 “C 03*‘ 3? “C tints: it»-Mb 108 was intarrmized,
`
`MA?! 1.0% mid 1.-tumg Canes: Gmmiz
`
`fiat: ézffeécts t:1:f.MAb .108 on NSCLC grmvth ‘WM .inves»
`‘tigated in vitm. "{‘ab§e 2?: stmwta "that, using a cinxwgenitc
`tts:;ay, cezstttrznies t’¢:2.rtttt::;t using act} tines .?;‘~tCI»‘¥~‘~!23 tmd MCI»
`I~£i5’?. E36? (100 tags gar ant...) slightty ixmreavseci ‘NCI«§~‘§23
`grmvth and sigiztificantlgs im:rt:21.ss2ti Nf.'3§.«»Ht5'?
`‘gr£}\¥i1'§‘i.
`Mzkb I08 siightiy ctczcreaseti the ttumbrzr ef coitmiea at a
`{M pg per mt contxznimtian and Sig'I1ifi£Z‘.’<’m£§j;’ decreased
`the11urI1h£§f‘0§"Cfl}Ol1iBSformfid at t tag per mt... At 1 tag par
`mL, M../-Kb £033 sign.it’it:a.n7riy dte:vcr:,'~:asec3 N'Ci-.H33 and NCE»
`
`APOTEX EX. 1020-010
`
`

`
`i':",§' A1.
`
`Tabb: 2.
`
`IEi§‘f<':c‘:
`
`:3?‘ agents an NSCLC’ g.n;:swt}1 in v2‘m>*
`
`Cblmzieg aging ~::s=:¥E 11219:?
`
`M;*m35°?
`
`§{sx4{E(1€3%}
`mg g 34(23;s%;‘
`
`49:; €S{'?<Ws:e}
`32 5; 154%}?-
`9:»
`a2{z44%;
`
`
`1 ‘CH 1-'~
`
`
`
`30¢ 5{§£}£}‘¥f::»}
`23 x cm 35%}
`
`1{1Q{}%~}
`m : zgfimmgi
`025
`¢3{z25%}
`
`Agent
`
`None
`'i(}§} ngs’mL
`§i»:3§~?,
`MAB ms, in
`._ug,»*m1.
`MAB 293, hug!-"rni,
`igii, 1;,eg,»’rr1i¢
`
`""3322: mean m1<3n:.»' mam: :2: st.z2s‘:w:iard arm: :91‘ t17z€13.N2.£1I1 {$81205
`ihrea démcrininaxtizxras for can ‘iixze :\¥C.’.§—2~%?..3 and '?«£CiAHI:3~“.»‘
`is
`indicamé.
`
`"“I‘}1:e again adeicii is indicaam on the mi"1.
`‘P at .615.
`
`A.is«;.:, the efi‘=‘{:«z:is~; of mm; HES an 1‘°»FSCL£Z7 gmwih were
`'mv::stégm‘ea3 in vivo, Fig.
`shows that tumors (8 mm’?
`farmed 3 weeks 31%.: in':;3§anzai:ém of N{ZI»Z~i’?2'? cgfis 3.21:9
`rsmzie szxice.
`’I”'h::: u1rna;1,r31 gnaw eaxponanziaily, and afixrr §
`xxreeks £118 mesm tumm volurmz in the ;:«;amm1 was apprcm
`imataly §{}{}£} 2221133 fiimil:-1r msults mare etalitaizmi M1632: haw
`<:<m::sn1r;it:ions 0:“ rmb 10$ {'10 ,;;g, fintraperimnéeal} were
`adgminiswregi
`1 day aim" tumor 2211 impianiatian. when
`mmimzmz {£06 pg} :3: high (1 mg) quarztiiies :21’ Mm» 108
`were injected inxzraperiiuzmaily mg day 2, the tumor x-'+:31«
`mm: was mciuészed by a;:nm10:<im.a£e1y 6{3‘*}*a at wmises 4
`throlxgh E3. Them: data indicate thazé me tzffezzts of ?viAb £63
`in viva‘; are cio:~;e d¢T:p8I3£i€i‘1£.
`mme mi‘ axfixninistraziipn of MM 108 was im-*e3t§~
`fa sah<::w:: that in £3211 iim: E~ECI~1»i4véii3, xm.0gr£§f‘:S
`gazed.
`fornmi. after 2. weeks (3 mm}; and grew so ‘£h;1:‘g a: weak (1
`
`1 E
`
`10;»
`
`<22
`
`(37
`
`
`
`'3
`“*3
`
`
`
`Tamarvmume,mm32;H3
`
`..>"”""
`
` NWMA
`
`:
`'
`E
`53
`g
`1
`5%”
`*=
`E
`=
`I
`E
`:
`
`".
`
`g
`x
`
`Q
`
`'\
`V»,
`K
`\
`
`‘K.
`‘"3
`
`‘xx
`s
`s
`3
`
`K
`‘K
`*3‘
`410;,“
`30
`
`W
`‘B0
`
`3° farm
`
`JHL
`“~
`E
`1:?
`i
`3
`3

`
`15
`
`10
`
`xv‘
`I’!z
`2
`4?
`3
`'
`.5
`E?
`:5
`'
`5
`5'
`S;
`.-
`1
`
`“
`E
`3
`E
`w
`
`16
`
`SE3
`
`fM&3§1§35},
`
`ficM
`
`’”£«-l\e‘iAh 18$
`3. Einding m” ”5‘i~?\e§..?x1> H38, Left: "€19: ammam M‘
`bmmxj m 'Nt;Ti«§~i»16£} (1.3 X 10" cam) sgrsecsificrfliy was tietermisierd
`a
`functkzr-.~ 02" MAB mza >:<mm:::m21i::m.. }Z.igh$.: £§::azr;:ha;‘d 1120‘; m“ the
`aific bimiéng dam.
`
`r:=:’§a1.ix-'e to mmroi
`r::ss3ms:£.i~.-*e§y,
`H15”? in 50% and ~'18“.5’:>,
`vafiucts. in c0m;rast.. ::z,m£.m1 igffs giighily incxv:-aged the a:a,¥«
`any xxumizer at .3 3 pg per mi. cm1cmirati0n.. These dam
`imiiszaiaa ma: EKYSF and cstsnmzd amiE::o«:ig.r Zgfl stiméazlam
`mixmy i’(:«r::na£ir;m W.?Ti(Z¥‘t2:EiS Mfih N138 inhiizim gmwzh. Sim»
`iiar data mwrsa obtained using mi} lines §‘«¥{7i‘—§~{?2?3 §‘*é(?1~
`H833, am; §%J€ZTI+}-£i.2.*§i9.
`
`........
`4"’c--~.3?°c
`
`H23
`
`H460
`
`0‘: C39
`
`
`
`
`
`*5Speciféc125%-MAl:a1:33bmznci
`
`Temperatéura
`
`'¥":m=sa1 weaks
`
`‘“‘E~;\«1,<Kh £08 was izswtsafed
`Inzer::a¥i3,3€i::m ea? ”"1~F‘v‘£M> 1188,
`Fig, 4,
`with wit lint: NC!-H23 aw! ‘NCI~H-1350 far 2‘; §:um'.s' as 4 “C or J3 htmm at‘
`<3 *6? grsiua S rsximaws $.11 37’ °C, The ;>s:vrm:nt:ag.e :33“
`*
`a*.c§‘i‘ia ‘3:"I~M.M: 1&8
`lfaunzd to {he €6.11 mnace {Ci} and i::.z:;4:‘m2ii;ws:i
`(‘i-:3‘:
`<§»:;e.rmme«:3
`{iiZt$€$1§)&fn;§
`_gm:*.=i«;ms.’i*,-‘ {M}.
`
`response mzm: fur MAE: ms inhibition af mmm g,m«wz?'z.
`Fig. 5.
`ccéis {.1117} were": injesrnxi 5uf:acu1a:':e«mzsiy 5.2‘: 62.3‘
`1 zmci 52: £321}; 2
`N€IH{‘?3‘?
`PBS {Q}, 10 pg .-.‘s~*EM:‘: 158

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket